| Literature DB >> 34678118 |
Karin Rilby1, Maziar Mohaddes2, Emma Nauclér3, Johan Kärrholm4.
Abstract
Background and purpose - The anatomical uncemented stem, SP-CL (Static Physiologicus - CementLess), designed to facilitate insertion and to avoid stress concentration at solitary contact points, has been on the market since 2014 but is not well documented. We studied its clinical performance, migration, and associated bone remodeling in a randomized controlled trial, with the Corail stem as control. Patients and methods - 79 patients (80 hips) were primarily recruited and 71 patients (72 hips, 36 SP-CL, 36 Corail) attended the last follow-up at 2 years. The Oxford Hip Score (OHS) was the primary outcome. In addition, we assessed stem migration, changes in bone mineral density, and development of radiolucencies by RSA, DXA, and conventional radiography. Results - At 2 years Oxford Hip Score was similar between the SP-CL and Corail stem. At 2 years the SP-CL stems showed a median distal migration of 0.23 mm (-0.1 to 5.2) and the Corail stems of 0.11 mm (-0.4 to 4.4). The SP-CL stems showed slightly more loss of bone mineral density in Gruen region 7 (p = 0.003). Interpretation - We found no difference in clinical results between the SP-CL and the well-documented Corail stem. The same stem stability was reached between 1 and 2 years postoperatively for both stems. As a next step we think that the SP-CL stem should be studied in a multi-center setting, before being accepted for general use.Entities:
Mesh:
Year: 2022 PMID: 34678118 PMCID: PMC8815675 DOI: 10.1080/17453674.2021.1993606
Source DB: PubMed Journal: Acta Orthop ISSN: 1745-3674 Impact factor: 3.717
Figure 1Flow chart.
Baseline demographics and choice of surgical approach. Values are count unless otherwise specified
| Factor | SP-CL n = 37 | Corail n = 38 |
|---|---|---|
| Age, mean (95% CI) | 58 (55–61) | 62 (60–64) |
| median (range) | 56 (41–73) | 62 (45–71) |
| Sex, male / female | 17 / 20 | 14 / 24 |
| Primary OA | 35 | 37 |
| Secondary OA | 2 | 1 |
| BMI, mean (95% CI) | 28 (27–29) | 26 (25–27) |
| median (range) | 27 (22–36) | 26 (21–34) |
| ASA class | ||
| 1 | 16 | 10 |
| 2 | 20 | 27 |
| 3 | 1 | 1 |
| ≥ 4 | 0 | 0 |
| Charnley class | ||
| A | 19 | 14 |
| B | 2 | 6 |
| C | 11 | 11 |
| missing | 5 | 7 |
| Smoking | ||
| No | 23 | 23 |
| previously | 7 | 5 |
| yes | 1 | 1 |
| missing | 6 | 9 |
| Surgical approach | ||
| posterior | 32 | 19 |
| direct lateral | 5 | 19 |
Figure 2Mean OHS (SEM) preoperatively, at 3 and 6 months, 1 and 2 years.
Patient-reported outcomes and Harris Hip Score. Values are count, median (range)
| Factor | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Type of stem | Preoperative | 3 months | 6 months | 1 year | 2 years | p-value [ | |||||
| Oxford Hip Score | |||||||||||
| SP-CL | 36 | 20 (5–36) | 34 | 43 (12–48) | 30 | 45 (12–48) | 34 | 46 (15–48) | 33 | 46 (17–48) | |
| Corail | 33 | 21 (5–33) | 35 | 43 (20–48) | 33 | 45 (24–48) | 28 | 46 (19–48) | 35 | 47 (19–48) | 1.0 |
| Harris Hip Score | |||||||||||
| SP-CL | 37 | 54 (12–80) | 31 | 99 (60–100) | 34 | 100 (67–100) | |||||
| Corail | 37 | 56 (7–83) | 34 | 99 (72–100) | 34 | 100 (68–100) | 0.8 | ||||
| Forgotten Joint Score | |||||||||||
| SP-CL | 35 | 5 (0–25) | 33 | 75 (2–100) | 34 | 72 (0–100) | |||||
| Corail | 33 | 6 (0–50) | 31 | 67 (8–100) | 35 | 83 (10–100) | 0.7 | ||||
| EQ-5D | |||||||||||
| SP-CL | 31 | 0.55 (0.06–0.73) | 36 | 0.93 (0.59–0.97) | 32 | 0.93 (0.61–0.97) | 34 | 0.93 (0.59–0.97) | 34 | 0.97 (0.59–0.97) | |
| Corail | 31 | 0.41 (−0.08–0.8) | 35 | 0.93 (0.61–0.97) | 36 | 0.93 (0.61–0.97) | 30 | 0.93 (0.61–0.97) | 36 | 0.93 (0.66–0.97) | 0.5 |
| EQ-VAS | |||||||||||
| SP-CL | 31 | 61 (7–95) | 37 | 80 (29–99) | 33 | 80 (19–100) | 34 | 84 (26–100) | 33 | 85 (39–99) | |
| Corail | 27 | 58 (5–95) | 37 | 86 (20–100) | 36 | 85 (20–98) | 31 | 90 (34–100) | 36 | 90 (19–100) | 0.9 |
| VAS Pain | |||||||||||
| SP-CL | 36 | 64 (9–84) | 37 | 10 (0–68) | 33 | 9 (0–73) | 34 | 5 (0–70) | 34 | 5 (0–58) | |
| Corail | 34 | 62 (29–82) | 37 | 10 (0–61) | 36 | 7 (0–70) | 30 | 3 (0–56) | 36 | 2 (0–50) | 0.3 |
| VAS Satisfaction | |||||||||||
| SP-CL | 37 | 4 (0–70) | 33 | 3 (0–97) | 34 | 2 (0–90) | 34 | 2 (0–99) | |||
| Corail | 37 | 6(0–71) | 36 | 3 (0–78) | 31 | 1 (0–64) | 36 | 1 (0–64) | 0.5 | ||
| Likert scale Satisfaction (1/2/3/4/5) [ | |||||||||||
| SP-CL | 37 | 0/1/2/1 2/22 | 33 | 1 /0/2/7/23 | 34 | 0/1 /3/3/29 | 34 | 1/0/1 /7/25 | |||
| Corail | 37 | 1 /3/2/5/26 | 36 | 2/1/2/7/24 | 31 | 0/2/2/6/21 | 36 | 0/1/3/3/29 | 0.6 | ||
SP-CL vs. Corail at 2 years
1 = very dissatisfied (VAS 71–100); 2 = dissatisfied (VAS 51–70); 3 = neither satisfied nor dissatisfied (VAS 31–50); 4 = satisfied (VAS 11–30); 5 = very satisfied (VAS 0–10).
Missing observations are caused by forms with incomplete data or patient exclusions according to Figure 1. VAS Pain and VAS Satisfaction are reported from 0 to 100 where 0 is the best result. EQ-VAS is reported from 0 to 100 where 100 is the best result.
Evaluation of Oxford Hip Score at 2 years in a linear regression model
| Comparison | Least square means | 95% CI |
|---|---|---|
| Model I (stem + preoperative OHS) | ||
| Corail | 43 | 40–45 |
| SP-CL | 43 | 41–46 |
| Corail-SP-CL | −0.7 | −4.3 to 2.9 |
| Model II (stem + preoperative OHS+ type of incision) | ||
| Corail | 43 | 40–45 |
| SP-CL | 43 | 40–46 |
| Corail-SP-CL | 0 | −4.0 to 4.0 |
Figure 3Mean EQ-VAS (SEM) preoperatively, at 3 and 6 months, 1 and 2 years.
Figure 4Mean medial–lateral (left), proximal–distal (middle), and anterior–posterior migration (right) up to 2 years in 36 SP-CL and 35 Corail stems with RSA data on each follow-up occasion.
Figure 5Proximal–distal case-by-case migration up to 2 years in individual SP-CL and Corail stems.
Femoral head translations, mm
| Factor Type of stem | Mean (95% CI) | Median (range) |
|---|---|---|
| Postoperative-2 years | ||
| Medial(+)/lateral(−) | ||
| SP-CL | 0.18 (0.07 to 0.28) | 0.13 (−0.55 to 1.2) |
| Corail | 0.25 (0.06 to 0.44) | 0.09 (−0.55 to 2.3) |
| Proximal(+)/distal(−) | ||
| SP-CL | −0.75 (−1.2 to −0.32) | −0.23 (−5.2 to 0.12) |
| Corail | −0.39 (−0.73 to −0.06) | −0.11 (−4.4 to 0.40) |
| Anterior(+)/posterior(−) | ||
| SP-CL | −0.94 (−1.5 to −0.37) | −0.27 (−6.3 to 0.63) |
| Corail | −0.79 (−1.2 to −0.39) | −0.45 (−4.9 to 0.68) |
| Total (vectorial sum of translations) | ||
| SP-CL | 1.4 (0.73 to 2.1) | 0.53 (0.05 to 8.2) |
| Corail | 1.1 (0.59 to 1.6) | 0.60 (0.05 to 6.8) |
| 1–2 years | ||
| Medial(+)/lateral(−) | ||
| SP-CL | 0.02 (−0.02 to 0.06) | 0.04 (−0.41 to 0.23) |
| Corail | −0.01 (−0.05 to 0.03) | −0.01 (−0.34 to 0.26) |
| Proximal(+)/distal(−) | ||
| SP-CL | −0.03 (−0.06 to 0.01) | −0.02 (−0.25 to 0.27) |
| Corail | −0.01 (−0.04 to 0.02) | −0.00 (−0.55 to 0.47) |
| Anterior(+)/posterior(−) | ||
| SP-CL | −0.06 (−0.11 to 0.00) | −0.07 (−0.36 to 0.51) |
| Corail | −0.03 (−0.11 to 0.04) | −0.02 (−0.27 to 0.25) |
| Total (vectorial sum of translations) | ||
| SP-CL | 0.22 (0.18 to 0.25) | 0.19 (0.06 to 0.55) |
| Corail | 0.23 (0.18 to 0.28) | 0.19 (0.07 to 0.60) |
Overall treatment effect SP-CL/Corail (3, 6, 12, 24 months)
| Direction or type of migration | Ratio of estimated geometric mean (95% CI) |
|---|---|
| Model 1 (stem, age, sex, visit, and stem by visit as explanatory variable) | |
| Medial or lateral | 1.0 (0.6–1.6) |
| Proximal or distal | 2.0 (0.95–4.0) |
| Anterior or posterior | 0.9 (0.5–1.8) |
| Total (vectorial sum of translations) | 1.2 (0.7–2.0) |
| Model 2 (as model 1 + choice of incision) | |
| Medial or lateral | 0.9 (0.5–1.6) |
| Proximal or distal | 2.7 (1.3–5.7) |
| Anterior or posterior | 0.9 (0.5–1.9) |
| Total (vectorial sum of translations) | 1.3 (0.7–2.2) |
Distribution of radiolucent lines according to Gruen regions
| Stem | Gruen region | |||||
|---|---|---|---|---|---|---|
| 1 | 7 | 8 | 9 | 13 | 14 | |
| SP-CL | 0 | 1 | 5 | 0 | 1 | 2 |
| Corail | 7 | 2 | 8 | 1 | 0 | 5 |
Regions not included had no radiolucent lines in any of the cases.
Postoperative bone mineral density related to Gruen regions and postoperative mean change at 6 and 24 months
| Gruen region | Type of stem | n | Postoperative mean BMD (95% CI) | n | 6 months change %. (95% CI) | n | 2 years change % (95% CI) |
|---|---|---|---|---|---|---|---|
| 1 | SP-CL | 35 | 0.77 (0.72–0.81) | 34 | −6.9 (−10 to −3.1) | 35 | −7.2 (−12 to −2.5) |
| Corail | 29 | 0.75 (0.70–0.80) | 28 | −6.9 (−10 to −3.7) | 29 | −5.7 (−9.3 to −2.1) | |
| 2 | SP-CL | 35 | 1.52 (1.46–1.59) | 34 | −5.3 (−8.0 to −2.5) | 35 | −6.7 (−13 to −0.8) |
| Corail | 29 | 1.55 (1.48–1.62) | 28 | −4.1 (−7.1 to 1.1) | 29 | −6.8 (−10 to −3.4) | |
| 3 | SP-CL | 35 | 1.75 (1.69–1.82) | 34 | −1.3 (−3.1 to 0.5) | 35 | −2.6 (−5.4 to 0.3) |
| Corail | 29 | 1.75 (1.68–1.82) | 28 | −0.1 (−2.6 to 2.3) | 29 | −2.5 (−4.6 to −0.3) | |
| 4 | SP-CL | 35 | 1.87 (1.80–1.94) | 34 | 0.3 (−1.3 to 1.9) | 35 | −1.6 (−4.3 to 1.3) |
| Corail | 29 | 1.83 (1.76–1.91) | 28 | 0.2 (−1.5 to 1.8) | 29 | −2.1 (−3.7 to −0.5) | |
| 5 | SP-CL | 35 | 1.87 (1.80–1.95) | 34 | 1.6 (−0.2 to 3.4) | 35 | 0.1 (−2.3 to 2.6) |
| Corail | 29 | 1.84 (1.75–1.93) | 28 | 1.4 (−0.2 to 2.9) | 29 | 2.7 (−0.7 to 6.0) | |
| 6 | SP-CL | 35 | 1.48 (1.41–1.55) | 34 | −6.6 (−11 to −2.7) | 35 | −3.9 (−8.0 to 0.1) |
| Corail | 29 | 1.42 (1.35–1.50) | 28 | −3.2 (−5.8 to 0.7) | 29 | 0.3 (−6.0 to 6.6) | |
| 7 | SP-CL | 35 | 1.29 (1.23–1.36) | 34 | −19 (−27 to −11) | 35 | −14 (−19 to −9.0) |
| Corail | 29 | 1.24 (1.14–1.34) | 28 | −15 (−19 to −11) | 29 | −11 (−18 to −4.0) |